The efficacy of Massive Transfusion Protocol / whole blood transfusion: An umbrella review

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 81

فایل این مقاله در 20 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_TRAUM-29-6_001

تاریخ نمایه سازی: 17 بهمن 1403

چکیده مقاله:

Introduction: Although massive transfusion protocol (MTP) has been used extensively in the treatment of patients with bleeding trauma, its actual efficacy remains unknown. This umbrella review of systematic reviews and meta-analyses aims to update the evidence and assess the impact of implementing MTP/ whole blood transfusion on the mortality of trauma patients.Methods: Data sources: This umbrella review searched Medline (via Ovid), Embase, PubMed, Cochrane Library, CINAHL databases, JBISRIR, Epistemonikos, EPPI-Centre, CRD, and PROSPERO for possible systematic reviews from inception until October ۲۰۲۳.  Study eligibility criteria, participants, and interventions: Reviews that reported data comparing different types of massive blood perfusion were included. The quality of studies was evaluated using the Joanna Briggs Institute (JBI) critical appraisal tool. Our study outcomes, ۳۰-day mortality, and ۲۴-hour mortality, were re-analyzed using Comprehensive Meta-Analysis Software (CMA ۳.۰).Results: Thirty studies met the eligibility criteria. Eventually, we included eight studies in the current meta-analysis. The calculated odds ratio (OR) and ۹۵% confidence interval (CI) for ۳۰-day mortality in MTP and non-MTP comparison was OR = ۰.۶۵۴, ۹۵% CI: ۰.۵۷۶, ۰.۷۴۱, P-value <۰.۰۰۱, and similarly, when comparing the whole blood group and blood component group, significant differences were found between the groups in terms of ۲۴h-mortality ۰.۷۶۳, (۹۵% CI: ۰.۶۰۸, ۰.۹۵۷), and P-value = ۰.۰۲۰. The results showed low heterogeneity among the studies.Conclusion: Our results support that MTP decreases ۳۰-day mortality compared to non-MTP. Furthermore, our analysis showed that whole blood transfusion decreases the odds of ۲۴-hour mortality compared to blood components.

نویسندگان

Hadi Sahrai

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran

Kosar Arefdehgani

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran

Nasim Hajipoor Kashgsaray

Emergency and Trauma Care Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Moloud Balafar

Emergency and Trauma Care Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Sina Hamzehzadeh

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran

Kavous Shahsavarinia

Research Center for Evidence-based Medicine, Iranian EBM Centre: A JBI Centre of Excellence, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

Hanieh Salehi-Pourmehr

Research Center for Evidence-based Medicine, Iranian EBM Centre: A JBI Centre of Excellence, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran